FTH
NasdaqCMFaeth Therapeutics, Inc.
$27.24
▼ -1.58 (-5.48%)
Price
-7.61% over 1D
Key statistics
Previous close$28.82
Day range26.26 – 30.10
52-week range7.20 – 37.90
Volume226.11K
CurrencyUSD
ExchangeNasdaqCM
Crowd sentiment
50Neutral
Insider activity
SEC EDGAR ↗Open-mkt buys
23
$1,188,763.08
Open-mkt sells
0
$0.00
Net flow
+1.19M
23 open-market trades
Showing 38 recent filings. 15 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Craver Josiah PAO | Grant / award | 30.82K | $0.00 | — | 2026-07-21 |
Parikh Anand Kiran Director, President and CEO | Grant / award | 398.02K | $0.00 | — | 2026-07-21 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 831 | $23.34 | $19,395.54 | 2026-06-29 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 1.91K | $22.95 | $43,834.50 | 2026-06-30 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 1.64K | $23.88 | $39,115.44 | 2026-06-30 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 4.26K | $24.98 | $106,289.90 | 2026-06-30 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 4.4K | $23.40 | $102,960.00 | 2026-07-01 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 600 | $24.22 | $14,532.00 | 2026-07-01 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 2.89K | $25.22 | $72,911.02 | 2026-06-24 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 3K | $25.98 | $77,940.00 | 2026-06-24 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 3.4K | $26.98 | $91,732.00 | 2026-06-24 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 100 | $27.77 | $2,777.00 | 2026-06-24 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 580 | $23.61 | $13,693.80 | 2026-06-26 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 4.21K | $24.90 | $104,878.80 | 2026-06-26 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 1.36K | $25.55 | $34,696.90 | 2026-06-26 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 100 | $26.39 | $2,639.00 | 2026-06-26 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 1.8K | $20.23 | $36,353.31 | 2026-06-22 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 1.12K | $20.82 | $23,276.76 | 2026-06-22 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 1.58K | $22.40 | $35,459.20 | 2026-06-22 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 3.33K | $23.28 | $77,499.12 | 2026-06-22 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 356 | $23.95 | $8,526.20 | 2026-06-22 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 6.84K | $24.12 | $164,884.32 | 2026-06-23 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 1.97K | $24.84 | $48,909.96 | 2026-06-23 |
STEPHENSON BRIAN C Chief Financial Officer | Buy (open market) | 425 | $25.91 | $11,011.75 | 2026-06-23 |
Parikh Anand Kiran Director, President and CEO | Buy (open market) | 2.81K | $19.76 | $55,446.56 | 2026-06-22 |
Parikh Anand Kiran Director, President and CEO | Option exercise | 45.25K | $1.16 | $52,492.32 | 2026-06-22 |
Parikh Anand Kiran Director, President and CEO | Option exercise | 8.21K | $1.16 | $9,527.08 | 2026-06-22 |
Parikh Anand Kiran Director, President and CEO | Option exercise | 45.25K | $0.00 | — | 2026-06-22 |
Parikh Anand Kiran Director, President and CEO | Option exercise | 8.21K | $0.00 | — | 2026-06-22 |
Ramasastry Saira Director | Grant / award | 25K | $0.00 | — | 2026-06-12 |
Parikh Anand Kiran Director, President and CEO | Conversion | 761.43K | — | — | 2026-06-15 |
Parikh Anand Kiran Director, President and CEO | Conversion | 761.43 | — | — | 2026-06-15 |
Hahn Stephen M. Director | Conversion | 44.76K | — | — | 2026-06-15 |
Hahn Stephen M. Director | Grant / award | 25K | $0.00 | — | 2026-06-12 |
Hahn Stephen M. Director | Conversion | 44.76 | — | — | 2026-06-15 |
Parikh Anand Kiran Director, President and CEO | Grant / award | 761.43 | — | — | 2026-02-17 |
Parikh Anand Kiran Director, President and CEO | Grant / award | 12.32K | — | — | 2026-02-17 |
Parikh Anand Kiran Director, President and CEO | Grant / award | 136.88K | — | — | 2026-02-17 |
Source: SEC EDGAR Forms 4/4A (CIK 1829802). Click an insider to open the original filing.
Social sentiment
50
Neutral
Volume-weighted across live social sources
StockTwitsLIVE
1 recent posts · no directional signal yet
Recent posts
@Jausman· StockTwits3d ago
$FTH 2nd
Latest news
Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls
The Fly·2d agoNeutral
Raymond James Initiates Faeth Therapeutics at Outperform
MT Newswires·2d agoBullish
Faeth Therapeutics' Experimental Cancer Drug Piktor Has Upside Potential, Oppenheimer Says
MT Newswires·5d agoNeutral
Oppenheimer Initiates Faeth Therapeutics at Outperform
MT Newswires·5d agoBullish
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire·Jul 23Neutral
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.